SEP 9, 2026 · PHASE 3 TRIAL
Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa
ClinicalTrials.gov
Phase 3 RCT with completed recruitment (437 participants) addressing a significant clinical question, but this registry record reports no results; evidence strength cannot be assessed without outcome data.
Reported
Sample size437
Primary endpoint28-day Mortality
Primary outcome assessment timepo…28 days from enrollment